# A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node Metastasis

> **NCT01821248** · PHASE2 · UNKNOWN · sponsor: **Kansai Hepatobiliary Oncology Group** · enrollment: 25 (estimated)

## Conditions studied

- Biliary Tract Cancer

## Interventions

- **DRUG:** Gemcitabine, Cisplatin, S-1

## Key facts

- **NCT ID:** NCT01821248
- **Lead sponsor:** Kansai Hepatobiliary Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-07-23
- **Primary completion:** 2016-09-27
- **Final completion:** 2019-02
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2019-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01821248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01821248, "A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node Metastasis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01821248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*